Antara and Revlimid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Antara (fenofibrate) and Revlimid (lenalidomide). Common drug interactions include plasmacytoma among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Antara and Revlimid. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Antara?

Antara has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 569 Antara users. Check the latest studies of Antara.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

13 people who take Antara and Revlimid together, and have interactions are studied.

What are the common drug interactions of Antara and Revlimid, by gender? *:

female:

Plasmacytoma (neoplasm of plasma cells (usually in bone marrow))
Asthenia (weakness)
Contusion (a type of hematoma of tissue in which capillaries)
Malaise (a feeling of general discomfort or uneasiness)
Platelet count decreased
Body height decreased
Pain in extremity

male:

Diarrhoea
Decreased appetite
Febrile neutropenia (fever with reduced white blood cells)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Thrombocytopenia (decrease of platelets in blood)
Bacteraemia (presence of bacteria in the blood)
Dehydration (dryness resulting from the removal of water)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Nausea (feeling of having an urge to vomit)
Ageusia (loss of taste functions of the tongue)

What are the common drug interactions of Antara and Revlimid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Asthenia (weakness)
Chest discomfort
Chest pain
Confusional state
Diarrhoea
Dizziness
Dyspepsia (indigestion)
Dyspnoea (difficult or laboured respiration)
Emotional distress

60+:

Anaemia (lack of blood)
Thrombocytopenia (decrease of platelets in blood)
Ageusia (loss of taste functions of the tongue)
Blood potassium decreased
Blood pressure increased
Decreased appetite
Diarrhoea
Dizziness postural
Dyspnoea exertional (breathlessness or shortness of breath)
Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 15.38%
Myelodysplastic Syndrome Unclassifiable (there are too few of one type of blood cell in the blood. the number of blasts in the bone marrow and blood is normal): 1 person, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%
Breast Cancer: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Antara and Revlimid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously